Table I.
Treatment | Size (nm) | PDI | ζ (mV) | EE (%) |
---|---|---|---|---|
Cab/lipo | 82.73±3.82 | 0.261 | −50.2±4.34 | 93.19±2.29a |
BioTL-Cab/lipo | 90.10±2.71 | 0.246 | −58.6±2.40 | 97.26±3.18a |
6-FAM/lipo | 90.98±1.21 | 0.245 | −45.4±1.50 | 89.63±3.12b |
BioTL-6-FAM/lipo | 96.98±1.24 | 0.273 | −55.8±2.04 | 83.63±3.05b |
EE% of Cab
EE% of 6-FAM. 6-FAM, 6-carboxy fluorescein; BioTL, biotinylated TLS1c; Cab, cabazitaxel; EE, encapsulation efficiency; lipo, liposome; PDI, polydispersity index.